Scott L. Friedman

Dr. Scott L. Friedman is Dean for Collaborative Research and Director of the Institute for Liver Research at Icahn School of Medicine at Mount Sinai, where he holds dual professorships in Medicine and Pharmacological Sciences. He previously served as faculty at UCSF and completed training at Harvard Medical School and UCSF. His pioneering research on hepatic stellate cells revolutionized understanding of liver fibrosis.

Research focuses on:

• Molecular pathways of hepatic fibrosis and cancer
• Development of anti-fibrotic therapeutics
• Clinical trials for chronic liver diseases
• Global burden of metabolic liver disorders

He leads the Fibrosis Research Center investigating stellate cell activation, anti-fibrotic compounds, and translational applications.

Award highlights:

• International Hans Popper Award (2003, 2004)
• China Friendship Award (2014)
• Fulbright Senior Scholar (1995)
• AAAS Fellow (2015)
• AGA Distinguished Achievement (2016)

As Division Chief since 2001, he expanded faculty from 5 to 25, increased NIH funding 5-fold, and oversees Mount Sinai's largest liver fellowship program. Currently advises 3 students and manages a research team including postdoctoral fellows.